News
Litecoin ETF approval talk grows as institutional interest rises, fueled by regulatory clarity and LTC’s increasing role in ...
The crypto market is going crazy with BNB, Litecoin, and XRP all chasing new all-time highs amid renewed activity on centralized exchanges. Even then, a sophisticated new contender, Remittix, is ...
MEI Pharma buys 929,548 LTC worth $110M, making it the first US public company with a Litecoin reserve and boosting optimism ...
Litecoin ($LTC) consolidates near $122 as ETF buzz grows. Analysts eye $160-$170 amid institutional interest & rising payment adoption.
State Street Investment Management has teamed up with Stablecoin Standard to educate traditional finance firms about ...
ZetaChain's (CRYPTO: ZETA) latest integration with the Sui (CRYPTO: SUI) blockchain could bring real capital flows and ...
Meanwhile, Litecoin led the gainers with an over 12% gain, sparking interest in large-cap and legacy altcoins.
MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.
San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...
Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...
Litecoin is rising as institutional demand and ETF hopes boost investor confidence. This momentum could push LTC towards $200 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results